“…However, in our opinion, it is beside the point to consider the survival of PMCWTs as a single group; actually, also in our experience, the 5-year survival ranges very widely from 80% for chondrosarcomas to 21% for osteosarcomas. Chondrosarcoma is the most common PMCWT and the grade of the tumour has been reported as the most important prognostic factor, together with an adequate resection [4,8,9,16] (as also reported by the recent series of the Scandinavian Sarcoma Group), with a 10-year survival of 92% in patients operated with wide margins compared with 47% for those with intralesional resections [21]; the first observation was not confirmed in our series, probably because of the low number of cases. Osteosarcomas are usually high-grade tumours and combined treatment is required; in spite of this, they often metastatise and survival is significantly lower as compared to other subgroups of PMCWTs [8,9].…”